Nuformix (LSE:NFX) Total Liabilities : £0.19 Mil (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Total Liabilities?

Nuformix's Total Liabilities for the quarter that ended in Sep. 2022 was £0.19 Mil.

Nuformix's quarterly Total Liabilities increased from Sep. 2021 (£0.17 Mil) to Mar. 2022 (£0.24 Mil) but then declined from Mar. 2022 (£0.24 Mil) to Sep. 2022 (£0.19 Mil).

Nuformix's annual Total Liabilities declined from Mar. 2020 (£0.38 Mil) to Mar. 2021 (£0.33 Mil) and declined from Mar. 2021 (£0.33 Mil) to Mar. 2022 (£0.24 Mil).

Nuformix Total Liabilities Historical Data

The historical data trend for Nuformix's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Total Liabilities Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Total Liabilities

Get a 7-Day Free Trial

0.53

0.82

0.38

0.33

0.24

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Total Liabilities	Get a 7-Day Free Trial									0.33	0.17	0.24	0.19	0.27

Nuformix Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nuformix's Total Liabilities for the fiscal year that ended in Mar. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.238	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.24

Total Liabilities	=	Total Assets (A: Mar. 2022 )	-	Total Equity (A: Mar. 2022 )
	=	4.976	-	4.738
	=	0.24

Nuformix's Total Liabilities for the quarter that ended in Sep. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.188	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.19

Total Liabilities	=	Total Assets (Q: Sep. 2022 )	-	Total Equity (Q: Sep. 2022 )
	=	4.78	-	4.592
	=	0.19

Nuformix Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nuformix's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.